Criteria to Guide Evaluation of Patients Under Investigation (PUI) for 2019-nCoV 2019-nCoV医学观察病例监测指导标准

Patients in the United States who meet the following criteria should be evaluated as a PUI for 2019-nCoV.

在美国，符合以下条件者为2019-nCoV医学观察病例。

Clinical Features 临床表现	&	Epidemiologic Risk 流行病学史
Fever¹ or signs/symptoms of lower respiratory illness (e.g. cough or shortness of breath) 发热¹或下呼吸道疾病的体征/症状（例如咳嗽或呼吸急促）	AND 以及	Any person, including health care workers, who has had close contact² with a laboratory-confirmed³ ^,4 2019-nCoV patient within 14 days of symptom onset 在症状发作起14天内与经实验室确诊^3，4的2019-nCoV患者密切接触²的任何人，包括医护人员
Fever¹ and signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath) 发热¹和下呼吸道疾病的体征/症状（例如咳嗽或呼吸急促）	AND 以及	A history of travel from Hubei Province, China⁵within 14 days of symptom onset 症状发作起14天内有中国⁵湖北省的旅居史
Fever¹ and signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath) requiring hospitalization⁴ 发热¹和需要住院的下呼吸道疾病的体征/症状（例如咳嗽或呼吸急促）⁴	AND 以及	A history of travel from mainland China⁵ within 14 days of symptom onset 症状发作起14天内有中国大陆的旅居史

Clinical Features

临床表现

Epidemiologic Risk

流行病学史

Fever¹ or signs/symptoms of lower respiratory illness (e.g. cough or shortness of breath)

发热¹或下呼吸道疾病的体征/症状（例如咳嗽或呼吸急促）

AND

以及

Any person, including health care workers, who has had close contact² with a laboratory-confirmed³ ^,4 2019-nCoV patient within 14 days of symptom onset

在症状发作起14天内与经实验室确诊^3，4的2019-nCoV患者密切接触²的任何人，包括医护人员

Fever¹ and signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath)

发热¹和下呼吸道疾病的体征/症状（例如咳嗽或呼吸急促）

AND

以及

A history of travel from Hubei Province, China⁵within 14 days of symptom onset

症状发作起14天内有中国⁵湖北省的旅居史

Fever¹ and signs/symptoms of a lower respiratory illness (e.g., cough or shortness of breath) requiring hospitalization⁴

发热¹和需要住院的下呼吸道疾病的体征/症状（例如咳嗽或呼吸急促）⁴

AND

以及

A history of travel from mainland China⁵ within 14 days of symptom onset

症状发作起14天内有中国大陆的旅居史

The criteria are intended to serve as guidance for evaluation. Patients should be evaluated and discussed with public health departments on a case-by-case basis if their clinical presentation or exposure history is equivocal (e.g., uncertain travel or exposure).

本标准旨在用于筛查评估。若疑似病例的临床表现或流行病学史模棱两可（例如，不确定的出行或暴露情况），则应与公共卫生部门逐案进行评估和讨论。

点击阅读

（邓睿编译）